SAFE-BioPharma Working Groups

Global Business and Regulatory Working Group (GBRWG)

Purpose

  • Discusses regulatory-related projects, details new use cases, and explores all business and regulatory related implementations and potential uses of the SAFE-BioPharma standard.

Frequency 

  • Meets monthly (second Thursday) via teleconference  at 11:00AM EST

Chair: vacant

EU Advisory Council (EUAC)

Purpose

  • Supports pilots with the EMA and explores EU-specific projects and issues

Frequency

  • Meetings  scheduled as-needed

Chair: Hans van Leeuwen, Merck

Technical Working Group (TWG)

Purpose

  • Discusses technical issues regarding digital identities and credentials and their use in our industries.

Frequency

  • Meets monthly (third Wednesday) via teleconference at 10:00AM EST

Chair: Keith Respass, Merck
Co-chair: Peter Hesse, Gemini

Operations Services Group (OSUG)

Purpose

  • Discusses enhancements to the shared cooperative Registration Authority Service (RAS) and Universal Identity Service (UIS)

Frequency

  • Meets monthly (second Wednesday) via teleconference at 10:00AM EST  

Chair: Ann Plappert, Sanofi
Co-Chair: Rich Ware, AstraZeneca

Federation Working Group (FWG)

Purpose

  • Discusses using and accepting digital identities and credentials in federated identity management environments

Frequency

  • Meets monthly (Fourth Wednesday) via teleconference at 10:00AM EST

Chair: John Tryon, Merck